SCANCELL HOLDINGS PLC ORD 0.1P吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
29 0 公告 Continued improvement in PFS with iSCIB1+ SCANCELL HOLDING资讯 12-09 15:22
33 0 公告 Research Update SCANCELL HOLDING资讯 11-07 15:22
29 0 公告 Result of AGM SCANCELL HOLDING资讯 10-30 23:33
36 0 公告 Notice of AGM SCANCELL HOLDING资讯 10-03 14:18
40 0 公告 Director Dealing SCANCELL HOLDING资讯 09-16 14:20
34 0 公告 Final Results SCANCELL HOLDING资讯 09-11 14:22
44 0 公告 Notice of Results SCANCELL HOLDING资讯 09-04 14:28
47 0 公告 Director Dealing SCANCELL HOLDING资讯 08-08 19:33
44 0 公告 Director/PDMR Shareholding SCANCELL HOLDING资讯 08-04 17:26
46 0 公告 Strong Phase 2 data on iSCIB1+ in Melanoma SCANCELL HOLDING资讯 07-22 14:23
44 0 公告 Share Option Exercise SCANCELL HOLDING资讯 07-16 14:22
37 0 公告 Scancell initiates new arm in SCOPE Phase 2 study SCANCELL HOLDING资讯 06-25 14:15
39 0 公告 Director Dealing SCANCELL HOLDING资讯 05-21 14:21
55 0 公告 Partnership with NHS Cancer Vaccine Launch Pad SCANCELL HOLDING资讯 04-14 14:14
48 0 公告 Scancell to present at 2025 AACR Annual Meeting SCANCELL HOLDING资讯 04-01 15:09
51 0 公告 Issue of share options SCANCELL HOLDING资讯 02-20 15:23
53 0 公告 Scancell presenting at AACR IO conference SCANCELL HOLDING资讯 02-17 15:11
65 0 公告 Interim Results SCANCELL HOLDING资讯 01-30 15:15
59 0 公告 Notice of Interim Results SCANCELL HOLDING资讯 01-23 15:12
60 0 公告 Modi-1 Vaccine Achieves Early Clinical Validation SCANCELL HOLDING资讯 01-09 15:16
81 0 公告 Result of Retail Offer and Total Voting Rights SCANCELL HOLDING资讯 12-09 19:44
87 0 公告 Result of Placing and Subscription SCANCELL HOLDING资讯 12-05 20:43
79 0 公告 Retail Offer for up to £1 million SCANCELL HOLDING资讯 12-05 02:06
81 0 公告 Proposed fundraise in excess of £8.5 million SCANCELL HOLDING资讯 12-05 02:04
79 0 公告 Second Commercial License Agreement with Genmab SCANCELL HOLDING资讯 12-04 15:16
66 0 公告 Positive data from Phase 2 SCOPE trial with SCIB1 SCANCELL HOLDING资讯 11-18 15:16
88 0 公告 Result of Annual General Meeting SCANCELL HOLDING资讯 10-25 22:31
87 0 公告 Holding(s) in Company SCANCELL HOLDING资讯 10-24 14:19
84 0 公告 Scancell Appoints Dr Phil L’Huillier as CEO SCANCELL HOLDING资讯 10-22 14:15
74 0 公告 Notice of AGM SCANCELL HOLDING资讯 10-01 14:21
78 0 公告 Results Year Ended 30 April 2024 SCANCELL HOLDING资讯 09-24 14:40
81 0 公告 Notice of Final Results SCANCELL HOLDING资讯 09-18 14:19
78 0 公告 Strategic Partnership with PharmaJet SCANCELL HOLDING资讯 09-17 14:15
66 0 公告 Scancell to attend upcoming conferences SCANCELL HOLDING资讯 09-02 14:16
67 0 公告 Scancell Appoints Dr Nermeen Varawalla as CMO SCANCELL HOLDING资讯 07-30 15:22
73 0 公告 Update from iSCIB1+ Clinical Advisory Meeting SCANCELL HOLDING资讯 07-24 15:08
79 0 公告 Appointment of Dr Florian Reinaud to the Board SCANCELL HOLDING资讯 07-10 15:09
77 0 公告 Extension of Convertible Loan Notes SCANCELL HOLDING资讯 07-02 15:08
77 0 公告 Block Listing Return and Total Voting Rights SCANCELL HOLDING资讯 07-01 17:58
86 0 公告 Change of Nominated Advisor SCANCELL HOLDING资讯 06-21 15:19
92 0 公告 Agreement with major biotech SCANCELL HOLDING资讯 06-12 15:37
71 0 公告 Scancell to attend upcoming conferences SCANCELL HOLDING资讯 05-31 15:08
70 0 公告 Update on ModiFY trial SCANCELL HOLDING资讯 05-30 15:09
64 0 公告 Scancell to present at ASCO Annual Meeting SCANCELL HOLDING资讯 05-24 15:08
68 0 公告 Issue of share options SCANCELL HOLDING资讯 05-21 15:07
75 0 公告 Presenting at the Sachs 10th Annual Oncology Forum SCANCELL HOLDING资讯 05-16 15:08
73 0 公告 Scancell presenting at 21st CIMT Annual Meeting SCANCELL HOLDING资讯 05-09 15:08
79 0 公告 Presenting at the Annual Immuno-Oncology Summit SCANCELL HOLDING资讯 04-17 15:07
71 0 公告 Block Listing Six Monthly Return SCANCELL HOLDING资讯 04-16 15:07
69 0 公告 Employee exercise of share options SCANCELL HOLDING资讯 04-03 15:08
89 0 公告 Scancell to Present at 2024 AACR Annual Meeting SCANCELL HOLDING资讯 04-02 15:10
75 0 公告 Scancell Appoints WG as Joint Broker SCANCELL HOLDING资讯 03-28 22:28
65 0 公告 First iSCIB1+ patient dosed SCANCELL HOLDING资讯 03-26 21:27
84 0 公告 Appointment of Sath Nirmalananthan to the Board SCANCELL HOLDING资讯 03-14 20:23
68 0 公告 Scancell Attendance at Upcoming Conferences SCANCELL HOLDING资讯 03-12 16:08
83 0 公告 Presenting at Next-Gen Immuno-Oncology Conference SCANCELL HOLDING资讯 03-04 16:07
84 0 公告 Change of Auditor SCANCELL HOLDING资讯 02-20 16:09
106 0 公告 Directorate Change SCANCELL HOLDING资讯 02-05 17:25
80 0 公告 Interim Results SCANCELL HOLDING资讯 01-30 16:22
129 0 公告 Notice of Interim Results and Presentation SCANCELL HOLDING资讯 01-26 00:00
87 0 公告 Update on SCOPE trial SCANCELL HOLDING资讯 01-17 22:52
93 0 公告 Holding(s) in Company SCANCELL HOLDING资讯 12-29 02:43
87 0 公告 Holding(s) in Company SCANCELL HOLDING资讯 12-27 20:43
104 0 公告 Result of the Open Offer SCANCELL HOLDING资讯 12-19 16:08
95 0 公告 PDMR Notification SCANCELL HOLDING资讯 12-06 21:48
92 0 公告 Results of Placing SCANCELL HOLDING资讯 12-01 16:10
77 0 公告 Proposed Capital Raise to raise approximately £6m SCANCELL HOLDING资讯 12-01 02:07
99 0 公告 Result of AGM SCANCELL HOLDING资讯 11-29 23:43
93 0 公告 Update on SCOPE trial SCANCELL HOLDING资讯 11-28 16:09
88 0 公告 Scancell to present at 20th SMR Congress SCANCELL HOLDING资讯 11-10 17:43
84 0 公告 Scancell to present at 38th Annual SITC meeting SCANCELL HOLDING资讯 11-01 16:10
102 0 公告 Notice of AGM SCANCELL HOLDING资讯 10-31 21:03
75 0 公告 Results for the Year Ended 30 April 2023 SCANCELL HOLDING资讯 10-31 16:11
95 0 公告 Update on Final Results SCANCELL HOLDING资讯 10-20 15:10
101 0 公告 Scancell to speak at World Vaccine Congress Europe SCANCELL HOLDING资讯 10-18 15:09
91 0 公告 Block Listing Six Monthly Return SCANCELL HOLDING资讯 10-17 15:12
97 0 公告 Change of Date for Final Results SCANCELL HOLDING资讯 10-11 15:10
97 0 公告 Notice of Final Results and Investor Presentation SCANCELL HOLDING资讯 10-03 15:11
112 0 公告 Positive data from Phase 2 SCOPE trial with SCIB1 SCANCELL HOLDING资讯 09-19 15:11
99 0 公告 Scancell to present three posters at ICI SCANCELL HOLDING资讯 09-14 15:19
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500